News

Upcoming Venus Concept Financial Results for Fiscal Year 2025

Upcoming Venus Concept Financial Results for Fiscal Year 2025

Venus Concept Set to Announce Fiscal Year 2025 Results

Venus Concept Inc. is an innovative leader in the medical aesthetic technology industry. As anticipation builds in the business community, it has been announced that the company will release its first quarter financial results for the fiscal year 2025. This important update is scheduled before the market opens on a Thursday in mid-May.

Conference Call Details

On the day of the financial results release, the management team at Venus Concept will also host a conference call designed for investors and stakeholders. This call is set to begin at 8:00 a.m. Eastern Time, providing an insightful discussion on the results from the previous quarter, along with a question and answer session. For those wishing to join the discussion, a dedicated phone line will be available to dial in.

How to Participate in the Conference Call

Participants can engage in the conference call by dialing either 877-407-2991 for callers within the U.S. or 201-389-0925 for those calling from abroad. It’s important to have the code available for access during the call.

Replay Options for Participants

If anyone is unable to attend the live session, there's good news: a replay of the call will be made available. This recorded version will be accessible for two weeks following the event, allowing stakeholders to catch up on the essential details. The provided playback numbers allow for easy access to the replay.

Understanding Venus Concept's Position in the Market

Venus Concept has carved a niche as a global leader in medical aesthetic technology, boasting a diverse product line that features state-of-the-art solutions. This company excels in providing both minimally and non-invasive options, catering to the demands and preferences of patients worldwide. Their impressive reach extends across over 60 countries, with 12 direct markets highlighting their international impact.

Innovative Product Offerings

Part of what sets Venus Concept apart is their extensive portfolio of aesthetic devices. This includes notable products such as Venus Versa, Venus Legacy, and the cutting-edge Venus Bliss MAX. They also offer advanced hair restoration systems, featuring NeoGraft and the ARTAS iX Robotic system, which represent the forefront of technology in this evolving industry.

Support from Industry Leaders

Backing from prestigious equity investors is a significant highlight of Venus Concept’s journey. Support from organizations like EW Healthcare Partners, HealthQuest Capital, and others has facilitated their growth and innovation, positioning them as a powerhouse in healthcare technology.

Frequently Asked Questions

What is the date for Venus Concept's financial results release?

The financial results for the first quarter of fiscal year 2025 will be released before the market opens in mid-May.

How can I listen to the conference call?

You can listen in by dialing 877-407-2991 for U.S. callers or 201-389-0925 for international calls.

Is there a way to access the conference call after it has occurred?

Yes, a replay of the conference call will be available for two weeks after the initial call.

What products does Venus Concept offer?

Venus Concept provides a range of minimally invasive and non-invasive aesthetic devices and hair restoration technologies.

Who are the main investors in Venus Concept?

Key investors include EW Healthcare Partners, HealthQuest Capital, and Longitude Capital Management, among others.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rising Anxiety Claims in Pets: Insights from Trupanion

Updated Category News Views 94

Understanding Pet Anxiety: Trends and Tips Trupanion, Inc. (Nasdaq: TRUP) reports a notable increase in anxiety claims for pets. An examination of veterinary invoice data from over one million insured pets reveals that 2023 has marked a record high in both the total number of anxiety claims and the average number of claims per pet. It's important for pet owners to...

Continue Reading
Key Disclosure Insights from Man Group PLC and Centamin plc

Updated Category News Views 60

Important Information About Man Group PLC's Disclosure Man Group PLC has made a significant disclosure regarding its stake in Centamin plc, a company active in the mining and resource sector. These disclosures are key for grasping market dynamics and understanding how investors feel about the current landscape. Understanding the Disclosure Requirements This disclosure...

Continue Reading
Vivoryon Therapeutics Shares Insights on 2024 Financial and Business Progress

Updated Category News Views 194

Overview of Vivoryon Therapeutics Financial Results Vivoryon Therapeutics N.V. is pleased to share an insightful overview of its fiscal performance and strategic developments relating to its commitment toward innovative treatments, especially in the field of kidney disease. The company, specializing in small molecule medicines that modulate altered proteins, is making...

Continue Reading
SS Innovations Revolutionizes Robotic Surgery Landscape

Updated Category News Views 196

SS Innovations Sets New Standards in Robotic Surgery SS Innovations International, Inc. (OTC: SSII) has embarked on a remarkable journey to reshape the landscape of robotic surgery. With its award-winning SSi Mantra surgical robotic system successfully completing over 3,500 surgeries, the company continues to champion innovation, making advanced surgical technology...

Continue Reading
Aspen One Enhances Its Artistic Commitment and Programs

Updated Category News Views 248

Aspen One Strengthens Its Artistic Commitment Aspen One has announced a renewed dedication to art programming across its diverse portfolio, enhancing its long-standing Art in Unexpected Places initiative. This investment reaffirms the company’s commitment to supporting arts and artists, a fundamental aspect of its identity and community engagement. With a rich legacy of...

Continue Reading